Brief Title
Atrial Fibrillation, Stroke, and Bleeding in Patients Undergoing Aortic Biovalve Implantation
Official Title
Atrial Fibrillation, Stroke, and Bleeding in Patients Undergoing Aortic Biovalve Implantation
Brief Summary
The primary purpose of the FIN-bioAVR registry is to assess the incidence of AF, strokes and major bleeding events in patients undergoing aortic valve replacement. This retrospective multicenter registry will include 850 patients with aortic valve replacement using bioprosthesis.
Study Type
Observational
Primary Outcome
Stroke
Condition
Atrial Fibrillation
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Estimated Enrollment
850
Start Date
January 2002
Completion Date
December 2015
Primary Completion Date
December 2015
Eligibility Criteria
Inclusion Criteria: - patients undergoing aortic valve bioprosthesis implantation Exclusion Criteria: - mechanical heart valves in any position
Gender
All
Ages
18 Years - 99 Years
Accepts Healthy Volunteers
No
Contacts
Tuomas Kiviniemi, MD, PhD, ,
Location Countries
Finland
Location Countries
Finland
Administrative Informations
NCT ID
NCT02626871
Organization ID
T39/2015
Responsible Party
Principal Investigator
Study Sponsor
University of Turku
Collaborators
Helsinki University Central Hospital
Study Sponsor
Tuomas Kiviniemi, MD, PhD, Principal Investigator, Turku University Hospital
Verification Date
May 2017